Wells Fargo’s iShares Biotechnology ETF IBB Stock Holding History

Wells Fargo’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-100	Closed	-$12.7K	–	7226
2025 Q2	$12.7K	Buy	+100	New	+$12.3K	﹤0.01%	5891
2024 Q4	–	Sell	-30,000	Closed	-$4.37M	–	7125
2024 Q3	$4.37M	Hold	30,000	–	–	﹤0.01%	2446
2024 Q2	$4.12M	Hold	30,000	–	–	﹤0.01%	2408
2024 Q1	$4.12M	Buy	+30,000	New	+$4.1M	﹤0.01%	2412
2023 Q2	–	Sell	-200	Closed	-$25.8K	–	7631
2023 Q1	$25.8K	Buy	+200	New	+$26.2K	﹤0.01%	5531
2022 Q4	–	Sell	-12,100	Closed	-$1.42M	–	7575
2022 Q3	$1.42M	Buy	+12,100	New	+$1.5M	﹤0.01%	2994
2020 Q2	–	Sell	-100	Closed	-$1K	–	6516
2020 Q1	$1K	Sell	100 -103,200	-100%	-$11.9M	﹤0.01%	6060
2019 Q4	$4K	Hold	103,300	–	–	﹤0.01%	6074
2019 Q3	$659K	Buy	103,300 +100	+0.1%	+$10.5K	﹤0.01%	4175
2019 Q2	$444K	Buy	+103,200	New	+$11M	﹤0.01%	4455
2018 Q2	–	Sell	-19,600	Closed	-$82K	–	6427
2018 Q1	$82K	Buy	+19,600	New	+$2.17M	﹤0.01%	5389
2014 Q2	–	Sell	-158,400	Closed	-$504K	–	6186
2014 Q1	$504K	Buy	+158,400	New	+$13.2M	﹤0.01%	3870

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo's IBB Position: Q2 2026 in Review

Wells Fargo increased its iShares Biotechnology ETF (IBB) stake by 21% in Q2 2026, buying an estimated $30.1M and bringing the position to 1,029,643 shares worth $196M. The position accounts for 0.03% of the portfolio, ranked #436.

Wells Fargo first reported a position in IBB in Q2 2013 and has held it in 53 quarters since. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Wells Fargo held 1,029,643 shares of iShares Biotechnology ETF worth $196M as of Q2 2026.
Wells Fargo bought 175,298 iShares Biotechnology ETF shares in Q2 2026, an estimated $30.1M.
iShares Biotechnology ETF made up 0.03% of Wells Fargo's portfolio in Q2 2026, its #436 holding.
Wells Fargo first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 53 quarters since.
956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.